Proscia
Enterprise digital pathology platform using AI to accelerate medical research and diagnosis from tissue samples.
| What is it | Enterprise digital pathology platform using AI to accelerate medical research and diagnosis from tissue samples. |
|---|---|
| Pricing | Contact for Pricing |
| Platform | Web Application |
| API | Yes |
| Best for | Digitizing and analyzing pathology slides for cancer diagnosis, Accelerating drug discovery and biomarker research in clinical trials |
| Domain registered | 2009 |
Data updated Aug. 1, 2026
What does Proscia do?
Proscia is an enterprise software platform built specifically for the field of pathology. Its core function is to help medical professionals and researchers digitize, manage, and analyze pathology images—primarily microscope slides of tissue samples. By moving this traditionally analog process into a centralized digital environment, Proscia aims to streamline workflows, enable remote collaboration, and unlock new insights from pathology data.
The platform is not a single tool but a suite of purpose-built products. Concentriq serves as the foundational digital pathology platform, with versions tailored for life sciences research (LS) and anatomic pathology (AP), including an FDA-cleared module for primary diagnosis. What makes Proscia stand out is its deep integration of artificial intelligence. The AI portfolio provides scientists and pathologists with tools to develop and deploy AI models that can, for example, help identify patterns in tissue samples much faster than manual review. A companion product, Proscia Aperture, focuses on turning this data into real-time, actionable insights at the moment of diagnosis.
This tool is designed for a highly specialized professional audience. Pathologists in hospitals, health systems, and commercial labs benefit by modernizing their diagnostic workflows, potentially improving accuracy and turnaround times. Simultaneously, researchers and teams at pharmaceutical companies and contract research organizations (CROs) use Proscia to accelerate therapy development, from early biomarker discovery to late-stage clinical trials. In essence, Proscia is for any organization looking to leverage digital pathology and AI to advance precision medicine and improve patient outcomes.
Key features
What makes it stand outWho is Proscia for?
Who benefits most from this toolTrust & presence
Alternatives in Medical Image Analysis
AI-powered digital pathology platform for reviewing tissue slides, accelerating drug discovery, and managing GLP-compliant studies.
AI platform for pathologists that analyzes tissue slides to detect cancer and over 100 diagnostic features in seconds
Clinical AI platform that analyzes medical scans to help doctors detect strokes, aneurysms, and other critical conditions faster.
AI-powered clinical trial data analysis platform that automates endpoint adjudication and medical image review
AI-powered medical imaging software for early cancer detection and precision oncology diagnostics
AI platform that analyzes medical scans to help hospitals prioritize critical cases and coordinate care.
AI-powered medical imaging platform for early breast cancer detection, density assessment, and risk evaluation.
AI-powered OCT scan analysis for ophthalmologists and optometrists — detects pathologies, quantifies biomarkers, and supports clinical decisions.